My Quote Request
6505-01-232-3114
20 Products
NDC00053-4100-01
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012323114
NSN
6505-01-232-3114
NDC00053-4100-01
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012323114
NSN
6505-01-232-3114
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PARABEN AND PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00006-3514-74
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012323116
NSN
6505-01-232-3116
NDC00006-3514-74
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012323116
NSN
6505-01-232-3116
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 250.000 MILLIGRAMS IMIPENEM EQUIVALENT
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE CAPACITY OF NOT MORE THAN 20 ML,W/ADEQUATE SPACE FOR MIXING
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
PRIMAXIN
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012323116
NSN
6505-01-232-3116
PRIMAXIN
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012323116
NSN
6505-01-232-3116
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 250.000 MILLIGRAMS IMIPENEM EQUIVALENT
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE CAPACITY OF NOT MORE THAN 20 ML,W/ADEQUATE SPACE FOR MIXING
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
BRONDECON ELIRIX
OXTRIPHYLLINE AND GUAIFENESIN ELIXIR
NSN, MFG P/N
6505012323117
NSN
6505-01-232-3117
BRONDECON ELIRIX
OXTRIPHYLLINE AND GUAIFENESIN ELIXIR
NSN, MFG P/N
6505012323117
NSN
6505-01-232-3117
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS CHOLINE THEOPHYLLINATE PER MILLILITER AND 10.000 MILLIGRAMS GUAIFENESIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: CHERRY
III THERAPEUTIC EQUIVALENT: NOT RATED
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00071-2201-23
OXTRIPHYLLINE AND GUAIFENESIN ELIXIR
NSN, MFG P/N
6505012323117
NSN
6505-01-232-3117
NDC00071-2201-23
OXTRIPHYLLINE AND GUAIFENESIN ELIXIR
NSN, MFG P/N
6505012323117
NSN
6505-01-232-3117
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS CHOLINE THEOPHYLLINATE PER MILLILITER AND 10.000 MILLIGRAMS GUAIFENESIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: CHERRY
III THERAPEUTIC EQUIVALENT: NOT RATED
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-3482-54
KAOLIN AND PECTIN SUSPENSION
NSN, MFG P/N
6505012323118
NSN
6505-01-232-3118
NDC00054-3482-54
KAOLIN AND PECTIN SUSPENSION
NSN, MFG P/N
6505012323118
NSN
6505-01-232-3118
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 194.5 TO 200 GRAMS KAOLIN PER LITER AND 4.33 TO 4.40 GRAMS PECTIN PER LITER
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: NOT LISTED
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 180.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
411-2701
NIACIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505012324632
NSN
6505-01-232-4632
411-2701
NIACIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505012324632
NSN
6505-01-232-4632
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
NDC00364-1127-01
NIACIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505012324632
NSN
6505-01-232-4632
NDC00364-1127-01
NIACIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505012324632
NSN
6505-01-232-4632
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
470-1199
BUTABARBITAL SODIUM ELIXIR,USP
NSN, MFG P/N
6505012325216
NSN
6505-01-232-5216
470-1199
BUTABARBITAL SODIUM ELIXIR,USP
NSN, MFG P/N
6505012325216
NSN
6505-01-232-5216
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 MILLIGRAMS BUTABARBITAL SODIUM PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE III
III THERAPEUTIC EQUIVALENT: NOT RATED
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC00037-7011-99
BUTABARBITAL SODIUM ELIXIR,USP
NSN, MFG P/N
6505012325216
NSN
6505-01-232-5216
NDC00037-7011-99
BUTABARBITAL SODIUM ELIXIR,USP
NSN, MFG P/N
6505012325216
NSN
6505-01-232-5216
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 MILLIGRAMS BUTABARBITAL SODIUM PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE III
III THERAPEUTIC EQUIVALENT: NOT RATED
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC00364-0047-02
BUTABARBITAL SODIUM TABLETS,USP
NSN, MFG P/N
6505012329973
NSN
6505-01-232-9973
NDC00364-0047-02
BUTABARBITAL SODIUM TABLETS,USP
NSN, MFG P/N
6505012329973
NSN
6505-01-232-9973
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS BUTABARBITAL SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;WARNING AND CAUTION STATEMENTS:MAY BE HABIT FORMING;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE III;
THERAPEUTIC EQUIVALENT: NOT LISTED
Related Searches:
NDC00781-1367-10
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012330475
NSN
6505-01-233-0475
NDC00781-1367-10
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012330475
NSN
6505-01-233-0475
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
THERAPEUTIC EQUIVALENT: NOT RATED
Related Searches:
NDC00359-1154-10
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012330476
NSN
6505-01-233-0476
NDC00359-1154-10
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012330476
NSN
6505-01-233-0476
MFG
U S DEPT OF VETERANS AFFAIRS
Description
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 500.000 MG ELEMENTAL CALCIUM
Related Searches:
DIPROLENE
BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012331901
NSN
6505-01-233-1901
DIPROLENE
BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012331901
NSN
6505-01-233-1901
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/W
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 0.5 MG BETAMETHASONE EQUIVALENT PER GRAM; AUGUMENTED CREAM BASE OF PURIFIED WATER; PROPYLENE GLYCOL; CARBOMER 940; SODIUM HYDROXIDE; AAND TITANIUM DIOXIDE
THERAPEUTIC EQUIVALENT: DIPROLENE BY SCHERING
Related Searches:
DIPROLENE CREAM
BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012331901
NSN
6505-01-233-1901
DIPROLENE CREAM
BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012331901
NSN
6505-01-233-1901
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/W
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 0.5 MG BETAMETHASONE EQUIVALENT PER GRAM; AUGUMENTED CREAM BASE OF PURIFIED WATER; PROPYLENE GLYCOL; CARBOMER 940; SODIUM HYDROXIDE; AAND TITANIUM DIOXIDE
THERAPEUTIC EQUIVALENT: DIPROLENE BY SCHERING
Related Searches:
NDC00085-0728-01
BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012331901
NSN
6505-01-233-1901
NDC00085-0728-01
BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012331901
NSN
6505-01-233-1901
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/W
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 0.5 MG BETAMETHASONE EQUIVALENT PER GRAM; AUGUMENTED CREAM BASE OF PURIFIED WATER; PROPYLENE GLYCOL; CARBOMER 940; SODIUM HYDROXIDE; AAND TITANIUM DIOXIDE
THERAPEUTIC EQUIVALENT: DIPROLENE BY SCHERING
Related Searches:
DIMETAPP EXTENTABS
BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012333048
NSN
6505-01-233-3048
DIMETAPP EXTENTABS
BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012333048
NSN
6505-01-233-3048
MFG
ROBINS A H CO INC GOVERNMENT SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.000 MILLIGRAMS BROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 75.000 MILLIGRAMS PHENYLPROPANOLAMINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;
THERAPEUTIC EQUIVALENT: DIMETAPP EXTENTABS BY A H ROBINS
Related Searches:
NDC37969-0012-10
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505012334097
NSN
6505-01-233-4097
NDC37969-0012-10
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505012334097
NSN
6505-01-233-4097
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: RATED AP
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
5053-ED
ALLERGENIC EXTRACT,CANDIDA ALBICANS
NSN, MFG P/N
6505012334385
NSN
6505-01-233-4385
5053-ED
ALLERGENIC EXTRACT,CANDIDA ALBICANS
NSN, MFG P/N
6505012334385
NSN
6505-01-233-4385
MFG
HOLLISTER-STIER LABORATORIES LLC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALLERGENIC EXTRACT CANDIDA ALBICANS MULTI-DOSE VIAL 5ML
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
SPECIAL FEATURES: EA DROP IS SUFFICIENT FOR 1 TEST;APPROX. 175 TESTS;PROTEIN NITROGEN UNITS AVAIL. UPON REQUEST;SCRATCH TEST;ALCOHOL 10 PCT W/V 5ML VIAL
Related Searches:
4130-01
ETHIONAMIDE TABLETS,USP
NSN, MFG P/N
6505012334409
NSN
6505-01-233-4409
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ETHIONAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ETHIONAMIDE TABLETS USP 250 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,IVES LABS